Radioiodine in Low-Risk Thyroid Cancer | NEJM
1 ভিউ
• 07/06/23
0
0
বসান
administrator
সাবস্ক্রাইবার
Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3HvClQD
আরো দেখুন
ফেসবুক মন্তব্য
SORT BY-
শীর্ষ মন্তব্য
-
সর্বশেষ মন্তব্য